학술논문

Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
Document Type
Article
Source
In: Journal of Thoracic Oncology. (Journal of Thoracic Oncology, July 2024, 19(7):1108-1116)
Subject
Language
English
ISSN
15561380
15560864